AI in Organ Preservation: A Transformational Inflection Point for Transplant Medicine

Artificial intelligence is rapidly reshaping the transplant ecosystem — but most commentary focuses on organ allocation, rejection prediction, and clinical decision support. These advancements matter deeply, but they overlook a critical reality:

AI’s most immediate and transformative impact may actually occur before the organ reaches the recipient — inside the preservation device.

As a company building next‑generation preservation technologies, we see firsthand how AI is beginning to redefine the science, safety, and scalability of organ transplantation. What follows is a device‑centric view of where AI is already making a measurable difference, and where it will take the field next.

1. AI Is Expanding the Viability Window of Donor Organs

Recent analyses show that the organ preservation market is undergoing a major AI‑driven shift, with machine‑learning systems improving prediction of organ viability and optimization of preservation protocols. These models can detect subtle physiological changes long before they would be apparent to human operators, enabling:

• Early identification of ischemic injury

• Tailored adjustments to perfusion or temperature control

• Reduced risk of organ discard

For a company like ScubaTx — whose core mission is to deliver consistent, precise, hypothermic preservation — AI becomes a force multiplier. It enhances the performance of even the most advanced device by providing continuous, context‑aware optimisation.

2. AI Is Elevating Donor Organ Assessment From “Snapshots” to Real‑Time Insight

AI’s value is not simply better data analysis — it is the transition from episodic assessment to continuous monitoring. Reports across the field describe the emergence of real‑time AI systems capable of tracking organ health variables and flagging early deterioration patterns during preservation.

This matters because the industry is no longer satisfied with “keeping organs cold.”
We now aim to preserve organs intelligently — understanding their metabolic trajectory minute by minute.

For preservation device companies, this shifts the competitive landscape:
Devices must evolve from static machines into data‑driven biological observatories.

3. The Industry Is Moving Toward Multimodal Algorithms — and Preservation Devices Will Be Their Primary Data Source

At recent transplant AI symposia, researchers emphasised the need for multimodal models that combine clinical, immunological, and imaging data to guide transplant decisions. Preservation devices are central to this transition because they capture:

• Continuous perfusion or temperature data

• Pressure, flow, and metabolic indicators

• Time‑series data that clinicians rarely see today

The future transplant workflow will integrate device‑derived signals directly into viability scoring and organ allocation systems. That means organ preservation companies must engineer devices not only for thermal or mechanical precision but also for data interoperability with AI ecosystems.

4. AI Helps Turn Marginal Organs Into Transplantable Organs

From national analyses to investigative reviews, there is growing evidence that AI is improving the safe use of organs previously considered borderline or high‑risk. Market reviews highlight improved efficiency, reduced organ wastage, and increased utilization rates where AI‑supported preservation strategies are deployed.

This is aligned with the broader movement across transplant medicine to restore and rescue organs rather than discard them, as seen in innovations in perfusion science and bioengineering.

Preservation devices that integrate AI will have the ability to:

• Detect reversible deterioration

• Personalize the preservation environment

• Guide clinicians on recovery interventions during storage

In short: AI makes more organs usable — and safer.

5. Ethical and Regulatory Expectations Are Rising — AI Helps Meet Them

Thought leaders across the transplant field have emphasized the need for transparent, ethically grounded AI systems in clinical decision‑making. Device manufacturers are not exempt from this expectation.

AI embedded within preservation devices must be:

• Explainable

• Auditable

• Clinically validated

• Compliant with emerging regulatory frameworks for algorithmic medical devices

For a company scaling toward global clinical adoption, AI becomes not only a differentiator but a compliance enabler, providing standardized, documentable preservation quality.

6. Why Organ Preservation Is the Perfect Home for Near‑Term AI Deployment

Unlike complex human physiological systems, an organ in preservation is a closed, controlled, measurable environment — ideal for AI integration.

• No patient‑side variability

• Continuous sensor feedback

• Clear objective: maintain or improve organ viability

This makes preservation the ideal proving ground for many AI models before they move into more complex perioperative or post‑transplant settings.

7. What This Means for ScubaTx

AI does not replace our hardware — it supercharges it. The future of organ preservation will be defined by:

• Smart hypothermic preservation with adaptive thermal control

• Predictive deterioration models that anticipate organ decline

• Automated decision‑support for transplant coordinators

• Integration with OPO and transplant centre workflows

• Platform‑ready devices that support persufflation and future organ‑specific AI models

As transplant systems across the U.S. undergo reform and increased scrutiny, especially in OPO performance and allocation efficiency, AI‑driven preservation will be central to expanding access, improving outcomes, and reducing variability across centres.

**Conclusion:

AI Will Not Transform Transplant Alone — But It Will Transform Organ Preservation First**

The opportunity is clear:
Every hour an organ is outside the body is an hour where AI can make a measurable difference.

As the field evolves, preservation devices will move from passive containers to intelligent, predictive, and ultimately therapeutic platforms — and companies like ScubaTx must lead that transition.

If the future of transplantation is defined by precision, personalization, and efficiency, then AI‑powered preservation is the foundation upon which that future will be built.